OBI Pharma Inc (4174):企業の財務・戦略的SWOT分析

◆英語タイトル:OBI Pharma Inc (4174) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH429535FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a cancer vaccine for epithelial cancers other than breast and ovarian cancer. It also develops active immunotherapies intended for the treatment of various lung, prostate, pancreatic, stomach and ovarian cancers. OBI Pharma develops its pipeline products through its carbohydrate synthesis discovery platform. The company has collaboration with research institutes including cancer centers to enhance its pipeline products. It operates in the US, Taiwan and China. OBI Pharma is headquartered in Taipei, Taiwan.

OBI Pharma Inc Key Recent Developments

Jan 11,2021: OBI Pharma, Inc. to Present at the 39th J.P. Morgan Healthcare Conference
Sep 28,2020: Taiwan Hao Ding held a major news press conference

This comprehensive SWOT profile of OBI Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OBI Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

OBI Pharma Inc – Key Information
OBI Pharma Inc – Overview
OBI Pharma Inc – Key Employees
OBI Pharma Inc – Key Employee Biographies
OBI Pharma Inc – Key Operational Heads
OBI Pharma Inc – Major Products and Services
OBI Pharma Inc – History
OBI Pharma Inc – Company Statement
OBI Pharma Inc – Locations And Subsidiaries
OBI Pharma Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

OBI Pharma Inc – Business Description
OBI Pharma Inc – Corporate Strategy
OBI Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
OBI Pharma Inc – Strengths
OBI Pharma Inc – Weaknesses
OBI Pharma Inc – Opportunities
OBI Pharma Inc – Threats
OBI Pharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

OBI Pharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

OBI Pharma Inc, Key Information
OBI Pharma Inc, Key Ratios
OBI Pharma Inc, Share Data
OBI Pharma Inc, Major Products and Services
OBI Pharma Inc, History
OBI Pharma Inc, Key Employees
OBI Pharma Inc, Key Employee Biographies
OBI Pharma Inc, Key Operational Heads
OBI Pharma Inc, Other Locations
OBI Pharma Inc, Subsidiaries
OBI Pharma Inc, Key Competitors
OBI Pharma Inc, SWOT Analysis
OBI Pharma Inc, Ratios based on current share price
OBI Pharma Inc, Annual Ratios
OBI Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[OBI Pharma Inc (4174):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nuvia Ltd:企業の戦略的SWOT分析
    Nuvia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • BNY Mellon Wealth Management:企業の戦略・SWOT・財務情報
    BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report Summary BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Centre for Drug Research and Development-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides infrastructure to transform basic health research in academic institutions and early-stage therapeutic technologies into new medicines. The center offers target validation, screen …
  • Chugach Electric Association, Inc.:企業の発電所・SWOT分析2018
    Chugach Electric Association, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • Yantai Jereh Oilfield Services Group Co Ltd (002353):石油・ガス:M&Aディール及び事業提携情報
    Summary Yantai Jereh Oilfield Services Group Co Ltd (Yantai Jereh), formerly Yantai Jereh Equipment Group Co Ltd is an integrated oil and gas company that manufactures, designs, and markets oilfield equipment. The company offers oil and gas field equipment such as drilling and workover rig, simulati …
  • China Communications Construction Co Ltd:企業の戦略・SWOT・財務情報
    China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Silence Therapeutics Plc (SLN):企業の財務・戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a developer of therapeutics that channels gene silencing to cure life-threatening diseases. The company's pipeline products include SLN124, SLN500 and SLN360. Its SLN124 is developed for the treatment of cardiovascula …
  • BioStar Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Imperial Brands Plc:戦略・SWOT・企業財務分析
    Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report Summary Imperial Brands Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Offshore Oil Engineering Co Ltd (600583):石油・ガス:M&Aディール及び事業提携情報
    Summary Offshore Oil Engineering Co Ltd (COOEC), a subsidiary of China National Offshore Oil Corp, is a general engineering contractor that offers offshore engineering construction services. The company’s services include engineering, procurement, construction, installation, maintenance and underwat …
  • Hammond Manufacturing Company Ltd (HMM.A):企業の財務・戦略的SWOT分析
    Summary Hammond Manufacturing Company Ltd (Hammond) is a power company that develops, manufactures and distributes electrical and electronic devices. The company offers electrical enclosures, small enclosures, racks and rack cabinets, outlet strips, transformers, and chokes and reactors. Its transfo …
  • Freudenberg & Co KG:企業の戦略的SWOT分析
    Freudenberg & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Alfa SAB de CV (ALFAA):石油・ガス:M&Aディール及び事業提携情報
    Summary Alfa SAB de CV (Alfa) is a diversified company that operates in the petrochemical, refrigerated food, lightweight solutions, telecommunication, and oil and gas sectors. Alfa develops and manufactures high technology aluminum components for the power train and body structure of automotive. It …
  • PG&E Corp (PCG):電力:M&Aディール及び事業提携情報
    Summary PG&E Corp (PG&E) is an energy-based holding company. It has interests in Pacific Gas and Electric Company. PG&E generates, transmits, and distributes electricity. The company produces electricity using nuclear, hydro, fuel cell, solar, and fossil fuel sources. Through CPUC-approved procureme …
  • Altana Ag
    Altana Ag - Strategy, SWOT and Corporate Finance Report Summary Altana Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Libbs Farmaceutica Ltda:製薬・医療:M&Aディール及び事業提携情報
    Summary Libbs Farmaceutica Ltda (Libbs Farmaceutica) is a pharmaceutical company which manufactures and supply medications for human healthcare. The company offers monoclonal antibodies in various specialties which include cardiovascular, gynecology, oncology, dermatology, respiratory, and central n …
  • Fortive Corporation:企業の戦略・SWOT・財務情報
    Fortive Corporation - Strategy, SWOT and Corporate Finance Report Summary Fortive Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Kuwait Food Company (Americana) K.S.C.P. (FOOD):企業の財務・戦略的SWOT分析
    Kuwait Food Company (Americana) K.S.C.P. (FOOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Eguana Technologies Inc. (EGT)-エネルギー分野:企業M&A・提携分析
    Summary Eguana Technologies Inc. (Eguana), formerly Sustainable Energy Technologies Ltd, is a power electronics company. It designs, manufactures and supplies high performance power control solutions for grid interactive energy storage systems. The company’s power control solutions charge and discha …
  • Dana-Farber Cancer Institute Inc-医療機器分野:企業M&A・提携分析
    Summary Dana-Farber Cancer Institute Inc (Dana-Farber), formerly Sidney Farber Cancer Center is a cancer research center that offers treatment for different types of cancers. The center offers adults and children with various treatment options and also focuses on diagnosis, treatment, cure, and prev …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆